Compare ATNM & NPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATNM | NPT |
|---|---|---|
| Founded | 2000 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.9M | 29.7M |
| IPO Year | 2013 | N/A |
| Metric | ATNM | NPT |
|---|---|---|
| Price | $1.01 | $2.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | 105.6K | ★ 7.1M |
| Earning Date | 05-06-2026 | 05-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $90,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.11 | N/A |
| 52 Week Low | $0.95 | $1.14 |
| 52 Week High | $1.89 | $22.38 |
| Indicator | ATNM | NPT |
|---|---|---|
| Relative Strength Index (RSI) | 36.37 | 49.91 |
| Support Level | $0.99 | $1.19 |
| Resistance Level | $1.27 | $6.15 |
| Average True Range (ATR) | 0.07 | 1.05 |
| MACD | -0.02 | 0.27 |
| Stochastic Oscillator | 0.10 | 9.31 |
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.